Research and Markets - South Korea Proton Therapy Market - Key Players are IBA, Varian Medical Systems & Elekta

DUBLIN, Mar. 29, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "South Korean Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast" report to their offering.

The South Korean Proton Therapy Market is expected to almost triple by 2021 from its current market size in 2016. The Untapped Proton Therapy Market for South Korea was valued at more than 1 Billion USD in 2016.

Proton Therapy plays an important role in delivering comprehensive cancer care to children and adults at the National Cancer Center of Korea (KNCC, IIsan). Technological up-gradation in Proton Therapy that has more utilization rate will shorten the length of time per patient and it will further boost the proton therapy market.

The report studies the market in two parts a) Actual Market and b) Untapped Market.

a) Actual Market is the current market which is already present.
b) Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

South Korea Therapy Market has been analyzed from four view points:

• South Korea Proton Therapy Actual Market & Forecast (2009 - 2021)
• South Korea Proton Therapy Untapped Market & Forecast (2009 - 2021)
• South Korea Proton Therapy Treated Patient Volume & Forecast (2009 - 2021)
• South Korea Proton Therapy Untapped Patient Volume & Forecast (2009 - 2021)
  

Key Companies Covered:

• IBA
• Varian Medical Systems
• Elekta
  

Key Topics Covered:

1. Executive Summary

2. South Korea Proton Therapy Market - Actual & Untapped Market

3. South Korea Proton Therapy Patient - Actual & Untapped Patients

4. South Korea - List of Proton Therapy Centers

5. South Korea - Proton Therapy Treated Patients by Centers

6. Proton Therapy - Reimbursement Policies

7. Components of a Standard Proton Therapy Center

8. Global Proton Therapy - Company Analysis (2010-2021)

9. Proton Therapy - Driving Factors

10. Proton Therapy - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/455mh3/south_korean

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]